Checkpoint
CKPT

股本结构

单位：万股
公告日期 2025-05-13 2025-04-23 2025-03-28 2025-03-11 2025-03-28 2024-11-12
证券总股本 8702.00 8702.00 8376.37 6207.27 5434.04 4883.25
普通股本 8702.00 8702.00 8376.37 6207.27 5434.04 4883.25
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-05-09 2025-04-09 2025-03-25 2025-03-07 2024-12-31 2024-11-08
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-05-13 8702.00 未披露 定期报告 2025-05-09
2025-04-23 8702.00 未披露 定期报告 2025-04-09
2025-03-28 8376.37 未披露 定期报告 2025-03-25
2025-03-11 6207.27 未披露 定期报告 2025-03-07
2025-03-28 5434.04 未披露
更多>>
From December 31, 2023 to December 31, 2024 Issuance of common shares, net of offering costs - Registered direct offerings Issuance of common shares - Founders Agreement Exercise of prefunded and common stock warrants Stock-based compensation expense
2024-12-31
2024-11-12 4883.25 未披露 定期报告 2024-11-08
2024-11-12 4579.55 未披露
更多>>
From June 30, 2024 to September 30, 2024 Issuance of common shares - Founders Agreement Issuance of common shares, net of offering costs - Registered direct offering Exercise of pre-funded and common stock warrants
2024-09-30
2024-08-12 4501.78 未披露 定期报告 2024-08-08
2024-07-03 3808.03 未披露
更多>>
Common stock offered 1,230,000 shares by the company
2024-07-03
2024-08-12 4233.15 未披露
更多>>
From March 31, 2024 to June 30, 2024 Issuance of common shares - Founders Agreement Stock-based compensation expense Exercise of pre-funded and common stock warrants
2024-06-30
2024-05-10 3685.03 未披露 定期报告 2024-05-07
2024-03-22 3568.63 未披露 定期报告 2024-03-19
2024-01-30 2480.10 未披露
更多>>
Common stock offered 1,275,000 shares by the company
2024-01-31
2024-03-22 2774.20 未披露
更多>>
From December 31, 2022 to December 31, 2023 Stock-based compensation expense Issuance of common shares, net of offering costs - Registered direct offerings Issuance of common shares - Founders Agreement Exercise of prefunded and common stock warrants, including inducement
2023-12-31
2023-11-13 2352.60 未披露 定期报告 2023-11-10
2023-11-13 2240.25 未披露
更多>>
From June 30, 2023 to September 30, 2023 Issuance of common shares - Founders Agreement Exercise of prefunded and common stock warrants Issuance of common shares, net of offering costs - Registered direct offering
2023-09-30
2023-08-14 2159.35 未披露 定期报告 2023-08-10
2023-07-31 1972.08 未披露
更多>>
Common Stock offered by the company 2,427,186 shares
2023-07-31
2023-08-14 1793.84 未披露
更多>>
From March 31, 2023 to June 30, 2023 Issuance of common shares, net of offering costs - Registered direct offering Stock-based compensation expense Exercise of prefunded and common stock warrants Issuance of common shares - Founders Agreement
2023-06-30
2023-05-24 1729.36 未披露
更多>>
Common Stock offered by the company 1,650,000 shares
2023-05-25
2023-05-15 1564.36 未披露 定期报告 2023-05-12
2023-05-01 1564.79 未披露 定期报告 2023-04-17
2023-04-04 1464.66 未披露
更多>>
Common Stock offered 1,700,000 shares by the company
2023-04-04
2023-05-15 1390.11 未披露
更多>>
From December 31, 2022 to March 31, 2023 Issuance of common shares, net of offering costs - Registered direct offering Issuance of common shares - Founders Agreement Stock-based compensation expense Exercise of prefunded and common stock warrants
2023-03-31
2023-03-31 1294.66 未披露 定期报告 2023-03-24
2023-02-22 1143.19 未披露
更多>>
Common Stock offered 1,180,000 shares by the company
2023-02-23
2023-03-31 1028.67 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares, net of offering costs - Registered direct offering Issuance of common shares - Founders Agreement Net settlement of shares withheld for payment of employee taxes Stock-based compensation expense Fractional share adjustment
2022-12-31
2022-12-16 1025.19 未披露
更多>>
Common Stock offered 950,000 shares by the company
2022-12-16
2022-12-05 930.19 未披露
更多>>
Checkpoint Therapeutics, Inc. announced that it will effect a 1-for-10 reverse stock split of its issued and outstanding common stock.
2022-12-06
2022-11-10 9301.88 未披露 定期报告 2022-11-07
2022-11-10 9284.43 未披露
更多>>
From June 30, 2022 to September 30, 2022 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement Stock-based compensation expense
2022-09-30
2022-08-12 9249.70 未披露 定期报告 2022-08-10
2022-08-12 9190.58 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement Stock-based compensation expense
2022-06-30
2022-05-12 9102.64 未披露 定期报告 2022-05-09
2022-04-29 9089.14 未披露 定期报告 2022-04-18
2022-05-12 9080.12 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement Stock-based compensation expense Net settlement of shares withheld for payment of employee taxes
2022-03-31
2022-03-28 9059.01 未披露 定期报告 2022-03-23
2022-03-28 8457.44 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2021-12-31
2021-11-04 8377.31 未披露 定期报告 2021-11-02
2021-11-04 8321.44 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement
2021-09-30
2021-08-06 8274.19 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares – Founders Agreement Stock-based compensation expense
2021-06-30
2021-05-07 7918.38 未披露 定期报告 2021-05-04
2021-05-07 7916.38 未披露
更多>>
From December 31, 2020 to March 31, 2021 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement Stock-based compensation expense
2021-03-31
2021-03-12 7521.24 未披露 定期报告 2021-03-05
2021-03-12 6942.04 未披露
更多>>
From December 31, 2019 to December 31, 2020 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares, net of offering costs - Public offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2020-12-31
2020-11-06 6788.33 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common shares,net of offering costs-At-the-market offering Issuance of common shares,net of offering costs-Public offering Issuance of common shares-Founders Agreement Stock-based compensation expense
2020-09-30
2020-09-22 6512.29 未披露
更多>>
1.Common stock offered by the company 7,142,857 shares. 2.The number of shares of common stock to be outstanding after the offering is based on 57,980,004 shares of common stock and Class A common stock outstanding as of June 30, 2020.
2020-09-22
2020-08-06 6003.92 未披露 定期报告 2020-08-03
2020-08-06 5798.00 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares- Founders Agreement Stock-based compensation expense
2020-06-30
2020-05-07 5505.90 未披露 定期报告 2020-05-01
2020-05-07 5503.85 未披露
更多>>
from December 31, 2019 to March 06, 2020 Stock-based compensation expense Exercise of warrants
2020-03-06
2020-03-11 5400.48 未披露
更多>>
from December 31, 2018 to December 31, 2019 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares, net of offering costs - Public offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2019-12-31
2019-11-12 3821.97 未披露 定期报告 2019-11-03
2019-11-12 3816.60 未披露
更多>>
from June 30, 2019 to September 30, 2019 Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2019-09-30
2019-08-08 3799.56 未披露 定期报告 2019-08-05
2019-08-08 3696.00 未披露
更多>>
from March 31, 2019 to June 30,2019 Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2019-06-30
2019-05-10 3616.46 未披露 定期报告 2019-05-07
2019-05-10 3588.18 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2019-03-31
2019-03-18 3585.67 未披露 定期报告 2019-03-12
2019-03-18 3407.62 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of common shares, net of offering costs - Public offering Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2018-12-31
2018-11-02 3404.65 未披露 定期报告 2018-11-01
2018-11-02 3399.62 未披露
更多>>
from December 31, 2017 to September 30, 2018 Issuance of common shares, net of offering costs - Public offering Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2018-09-30
2018-08-07 3210.79 未披露
更多>>
from December 31, 2017 to June 30, 2018 Issuance of common shares for cash Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2018-06-30
2018-05-10 3201.51 未披露
更多>>
from December 31, 2017 to March 13, 2018 Issuance of common shares for cash Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2018-03-13
2018-03-16 2551.24 未披露
更多>>
from December 31, 2016 to December 31, 2017 Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
2017-12-31
2017-11-03 2550.79 未披露 定期报告 2017-11-01
2017-11-03 2536.86 未披露
更多>>
from December 31, 2016 to August 4, 2017 Stock-based compensation expense Issuance of common shares - Founders Agreement
2017-08-04
2017-08-09 2525.86 未披露
更多>>
From December 31, 2016 to June 30, 2017 Stock-based compensation expense Issuance of common shares - Founders Agreement
2017-06-30
2017-03-21 2442.69 未披露
更多>>
from December 31, 2015 to December 31, 2016 Issuance of common shares and warrants for cash Stock-based compensation expenses Issuance of common shares - Founders Agreement
2016-12-31
From December 31, 2023 to December 31, 2024 Issuance of common shares, net of offering costs - Registered direct offerings Issuance of common shares - Founders Agreement Exercise of prefunded and common stock warrants Stock-based compensation expense
From June 30, 2024 to September 30, 2024 Issuance of common shares - Founders Agreement Issuance of common shares, net of offering costs - Registered direct offering Exercise of pre-funded and common stock warrants
Common stock offered 1,230,000 shares by the company
From March 31, 2024 to June 30, 2024 Issuance of common shares - Founders Agreement Stock-based compensation expense Exercise of pre-funded and common stock warrants
Common stock offered 1,275,000 shares by the company
From December 31, 2022 to December 31, 2023 Stock-based compensation expense Issuance of common shares, net of offering costs - Registered direct offerings Issuance of common shares - Founders Agreement Exercise of prefunded and common stock warrants, including inducement
From June 30, 2023 to September 30, 2023 Issuance of common shares - Founders Agreement Exercise of prefunded and common stock warrants Issuance of common shares, net of offering costs - Registered direct offering
Common Stock offered by the company 2,427,186 shares
From March 31, 2023 to June 30, 2023 Issuance of common shares, net of offering costs - Registered direct offering Stock-based compensation expense Exercise of prefunded and common stock warrants Issuance of common shares - Founders Agreement
Common Stock offered by the company 1,650,000 shares
Common Stock offered 1,700,000 shares by the company
From December 31, 2022 to March 31, 2023 Issuance of common shares, net of offering costs - Registered direct offering Issuance of common shares - Founders Agreement Stock-based compensation expense Exercise of prefunded and common stock warrants
Common Stock offered 1,180,000 shares by the company
From December 31, 2021 to December 31, 2022 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares, net of offering costs - Registered direct offering Issuance of common shares - Founders Agreement Net settlement of shares withheld for payment of employee taxes Stock-based compensation expense Fractional share adjustment
Common Stock offered 950,000 shares by the company
Checkpoint Therapeutics, Inc. announced that it will effect a 1-for-10 reverse stock split of its issued and outstanding common stock.
From June 30, 2022 to September 30, 2022 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement Stock-based compensation expense
From March 31, 2022 to June 30, 2022 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement Stock-based compensation expense
From December 31, 2021 to March 31, 2022 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement Stock-based compensation expense Net settlement of shares withheld for payment of employee taxes
From December 31, 2020 to December 31, 2021 Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
From June 30, 2021 to September 30, 2021 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement
From March 31, 2021 to June 30, 2021 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares – Founders Agreement Stock-based compensation expense
From December 31, 2020 to March 31, 2021 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares - Founders Agreement Stock-based compensation expense
From December 31, 2019 to December 31, 2020 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares, net of offering costs - Public offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
From June 30, 2020 to September 30, 2020 Issuance of common shares,net of offering costs-At-the-market offering Issuance of common shares,net of offering costs-Public offering Issuance of common shares-Founders Agreement Stock-based compensation expense
1.Common stock offered by the company 7,142,857 shares. 2.The number of shares of common stock to be outstanding after the offering is based on 57,980,004 shares of common stock and Class A common stock outstanding as of June 30, 2020.
From March 31, 2020 to June 30, 2020 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares- Founders Agreement Stock-based compensation expense
from December 31, 2019 to March 06, 2020 Stock-based compensation expense Exercise of warrants
from December 31, 2018 to December 31, 2019 Issuance of common shares, net of offering costs - At-the-market offering Issuance of common shares, net of offering costs - Public offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from June 30, 2019 to September 30, 2019 Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from March 31, 2019 to June 30,2019 Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from December 31, 2018 to March 31, 2019 Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from December 31, 2017 to December 31, 2018 Issuance of common shares, net of offering costs - Public offering Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from December 31, 2017 to September 30, 2018 Issuance of common shares, net of offering costs - Public offering Issuance of common shares, net of offering costs - At-the-market offering Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from December 31, 2017 to June 30, 2018 Issuance of common shares for cash Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from December 31, 2017 to March 13, 2018 Issuance of common shares for cash Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from December 31, 2016 to December 31, 2017 Stock-based compensation expense Issuance of common shares - Founders Agreement Exercise of warrants
from December 31, 2016 to August 4, 2017 Stock-based compensation expense Issuance of common shares - Founders Agreement
From December 31, 2016 to June 30, 2017 Stock-based compensation expense Issuance of common shares - Founders Agreement
from December 31, 2015 to December 31, 2016 Issuance of common shares and warrants for cash Stock-based compensation expenses Issuance of common shares - Founders Agreement
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。